Vir Bio Ownership | Who Owns Vir Bio?

Overview Forecast RevenueFinancials Chart Transcripts

Vir Bio Ownership Summary

Vir Bio is owned by 80.14% institutional investors, 10.51% insiders, and 9.36% retail investors. Blackrock is the largest institutional shareholder, holding 12.15% of VIR shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.00% of its assets in Vir Bio shares.

VIR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Vir Bio	80.14%	10.51%	9.36%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock	16.43M	12.15%	$146.26M
Sb investment advisers (uk)	16.68M	12.05%	$84.09M
Blackrock funding, inc. /de	16.15M	11.67%	$81.41M
Vanguard group	13.13M	9.61%	$96.38M
Arch venture management	12.92M	9.33%	$65.10M
State street	5.09M	3.77%	$45.34M
Orbimed advisors	2.38M	1.72%	$12.00M
Geode capital management	2.20M	1.61%	$16.13M
Morgan stanley	2.12M	1.57%	$18.90M
Dimensional fund advisors lp	1.92M	1.40%	$14.06M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bill & melinda gates foundation	1.56M	23.22%	$13.88M
Arch venture management	12.92M	21.76%	$65.10M
Ikarian capital	1.07M	1.03%	$5.38M
Sio capital management	478.34K	0.92%	$2.41M
Sb investment advisers (uk)	16.68M	0.67%	$84.09M
Stonepine capital management	130.00K	0.64%	$655.20K
Tejara capital	258.60K	0.60%	$1.30M
Orbimed advisors	2.38M	0.30%	$12.00M
Adar1 capital management	250.00K	0.19%	$1.26M
Corton capital	22.53K	0.13%	$113.54K

Top Buyers

Holder	Shares	% Assets	Change
Arch venture management	12.92M	21.76%	12.92M
Jpmorgan chase	1.81M	0.00%	720.69K
Dimensional fund advisors lp	1.92M	0.00%	703.36K
Millennium management	1.72M	0.01%	610.37K
Nordea investment management ab	704.38K	0.00%	564.54K

Top Sellers

Holder	Shares	% Assets	Change
Baillie gifford	-	-	-2.38M
State street	5.09M	0.00%	-1.97M
Point72 asset management	-	-	-848.45K
Tang capital management	-	-	-500.00K
Woodline partners lp	-	-	-466.74K

New Positions

Holder	Shares	% Assets	Change	Value
Arch venture management	12.92M	21.76%	12.92M	$65.10M
Group one trading	179.26K	0.00%	179.26K	$1.32B
Susquehanna portfolio strategies	47.43K	0.01%	47.43K	$239.06K
Norges bank	28.90K	-	28.90K	$257.21K
Wolverine trading	23.41K	0.00%	23.41K	$171.57K

Sold Out

Holder	Change
Northwestern mutual wealth management	-5.00
Mendota financial group	-6.00
Dinuzzo private wealth	-6.00
Sjs investment consulting	-12.00
Nelson, van denburg & campbell wealth management group	-16.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	221	-6.75%	110,948,270	19.67%	80	1.76%	102	-18.40%	62	-11.43%
Mar 31, 2025	238	8.18%	93,178,710	4.94%	67	1.61%	125	10.62%	70	1.45%
Dec 31, 2024	204	-0.49%	66,639,809	-23.94%	48	1.19%	106	8.16%	64	-5.88%
Sep 30, 2024	204	-5.99%	87,613,923	-0.48%	64	1.54%	99	-11.61%	68	-2.86%
Jun 30, 2024	214	0.94%	88,011,508	-0.80%	65	1.50%	110	6.80%	70	9.38%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	5.56M	4.00%	994.00
Scottish Mortgage Ord	3.80M	2.78%	-
Vanguard Total Stock Mkt Idx Inv	3.51M	2.53%	-77.78K
Vanguard US Total Market Shares ETF	3.46M	2.52%	-
Vanguard Small Cap Index	2.68M	1.93%	-16.21K
iShares Russell 2000 ETF	2.12M	1.53%	-40.32K
SPDR® S&P Biotech ETF	1.60M	1.16%	39.49K
Vanguard Small Cap Growth Index Inv	1.50M	1.08%	-576.00
Vanguard Institutional Extnd Mkt Idx Tr	1.02M	0.74%	-442.82K
Biotech Growth Ord	943.70K	0.68%	943.70K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 02, 2025	SATO VICKI L	-	Sell	$109.81K
Aug 01, 2025	SATO VICKI L	-	Sell	$109.70K
Jul 15, 2025	Eisner Mark	EVP and Chief Medical Officer	Sell	$37.16K
Jul 17, 2025	Eisner Mark	EVP and Chief Medical Officer	Sell	$19.63K
Jul 01, 2025	SATO VICKI L	-	Sell	$112.21K

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	5
2025 Q2	-	2
2025 Q1	-	9
2024 Q4	-	4
2024 Q3	-	1

VIR Ownership FAQ

Who Owns Vir Bio?

Vir Bio shareholders are primarily institutional investors at 80.14%, followed by 10.51% insiders and 9.35% retail investors. The average institutional ownership in Vir Bio's industry, Biotech Stocks , is 306.59%, which Vir Bio falls below.

Who owns the most shares of Vir Bio?

Vir Bio’s largest shareholders are Blackrock (16.43M shares, 12.15%), Sb investment advisers (uk) (16.68M shares, 12.05%), and Blackrock funding, inc. /de (16.15M shares, 11.67%). Together, they hold 35.87% of Vir Bio’s total shares outstanding.

Does Blackrock own Vir Bio?

Yes, BlackRock owns 12.15% of Vir Bio, totaling 16.43M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 146.26M$. In the last quarter, BlackRock decreased its holdings by -129K shares, a -0.78% change.

Who is Vir Bio’s biggest shareholder by percentage of total assets invested?

Bill & melinda gates foundation is Vir Bio’s biggest shareholder by percentage of total assets invested, with 23.22% of its assets in 1.56M Vir Bio shares, valued at 13.88M$.

Who is the top mutual fund holder of Vir Bio shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Vir Bio shares, with 4.00% of its total shares outstanding invested in 5.56M Vir Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools